Physician's authorization is required to purchase this item.
Caldolor® is the first FDA-approved intravenous treatment for pain and fever designed primarily for use in adult patients in hospitals and surgery centers who are unable to receive oral therapies for pain relief and fever reduction. Clinical trials have shown Caldolor® to be safe and effective: It reduces fever, has beneficial anti-inflammatory properties and reduces pain while also reducing opioid consumption.
Improving Patient Care:
Following completion of a development program involving more than 1,400 patients, we received FDA approval for Caldolor® in June 2009. We launched the product in September of that year, and continued to introduce Caldolor® to hospitals and surgical centers across the country through our organization. During 2010, Caldolor® was stocked at a growing number of U.S. medical facilities. This was a result of a dedicated effort during the year to focus on individual hospital formulary approvals for the product. As a result, we were able to achieve approval and stocking of the product at a core group of medical facilities around the U.S. We then initiated a shift in strategy to begin driving pull-through use and corresponding sales of the product.